Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...

We've seen this shift before with some older models too like the iPhone 12, which was the first non-Pro model to get an OLED screen. This year, the iPhone 15 is the most exciting iPhone for me as it ...

One common type of mortgage is a conventional loan with a 15-year fixed interest rate. With a fixed rate, your rate and monthly payment will stay the same throughout the life of the loan.

One option to consider is refinancing to a conventional 15-year, fixed-rate loan. If you’re thinking about refinancing, be sure to keep an eye on interest rates beforehand as they tend to ...

Xiaomi 15 mobile was launched on 29th October 2024. The phone comes with a 120 Hz refresh rate 6.36-inch touchscreen display offering a resolution of 1200x2670 pixels (1.5K) and an aspect ratio of ...

Klinefelter syndrome is a trisomy of the sex chromosomes. Most commonly (around 82 percent of the time) there is an extra X chromosome (an XXY arrangement). In 10 to 15 percent of men with Klinefelter ...

A new blood test has the potential to identify a hard-to-predict but sometimes deadly pregnancy complication weeks before it would normally be found, leading to early treatment and possibly prevention ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

AEF0217 for cognitive disorders, which has completed a Phase 1/2 study in Spain in young adults with Down syndrome (Trisomy 21). The clinical results obtained with these 2 molecules have confirmed ...

Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... New Innovative Local ...

Sophia Smith was just 11 days old when she died in an intensive care unit at the Royal Hospital for Children in Glasgow in ...

Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 ...